LS-P-PATH

A Phase 1 Open-Label Study of PF-07934040 as a Single Agent and in Combination With Other Targeted Agents in Participants With Advanced Solid Tumors Harboring Mutations in the KRAS Gene

Status:

OPEN TO ACCRUAL

Trial Type:
Gastrointestinal, Thoracic
Age Group:
Adults
Phase:

I

NCT Number:

NCT06447662

Contact:

Safran, Howard

hsafran@BrownHealth.org